Porcine Milk Oligosaccharides and Sialic Acid Concentrations Vary Throughout Lactation by Austin T. Mudd et al.
September 2016 | Volume 3 | Article 391
Original research
published: 08 September 2016
doi: 10.3389/fnut.2016.00039
Frontiers in Nutrition | www.frontiersin.org
Edited by: 
Pietro Celi, 
DSM Nutritional Products, USA
Reviewed by: 
Barry Bradford, 
Kansas State University, USA 
Ricardo F. M. Teixeira, 
University of Lisbon, Portugal
*Correspondence:
Ryan N. Dilger 
rdilger2@illinois.edu
†Austin T. Mudd and Jaime Salcedo 
are equally contributing first authors.
Specialty section: 
This article was submitted to 
Animal Nutrition and Metabolism, 
a section of the journal 
Frontiers in Nutrition
Received: 02 June 2016
Accepted: 25 August 2016
Published: 08 September 2016
Citation: 
Mudd AT, Salcedo J, Alexander LS, 
Johnson SK, Getty CM, 
Chichlowski M, Berg BM, Barile D 
and Dilger RN (2016) Porcine Milk 
Oligosaccharides and Sialic 
Acid Concentrations Vary 
Throughout Lactation. 
Front. Nutr. 3:39. 
doi: 10.3389/fnut.2016.00039
Porcine Milk Oligosaccharides 
and sialic acid concentrations 
Vary Throughout lactation
Austin T. Mudd1†, Jaime Salcedo2†, Lindsey S. Alexander1, Stacey K. Johnson1,  
Caitlyn M. Getty1,3, Maciej Chichlowski4, Brian M. Berg3,4, Daniela Barile2,5 and  
Ryan N. Dilger1,3,6*
1 Piglet Nutrition and Cognition Laboratory, University of Illinois, Urbana, IL, USA, 2 Department of Food Science and Technology, 
University of California Davis, Davis, CA, USA, 3 Division of Nutritional Sciences, University of Illinois, Urbana, IL, USA, 4 Mead 
Johnson Pediatric Nutrition Institute, Evansville, IN, USA, 5 Foods for Health Institute, Food Science and Technology, University 
of California Davis, Davis, CA, USA, 6 Department of Animal Sciences, University of Illinois, Urbana, IL, USA
Background: Milk oligosaccharides (OSs) are bioactive components known to influence 
neonatal development. These compounds have specific physiological functions acting as 
prebiotics, immune system modulators, and enhancing intestine and brain development.
Objectives: The pig is a commonly used model for studying human nutrition, and there 
is interest in quantifying OS composition of porcine milk across lactation compared with 
human milk. In this study, we hypothesized that OS and sialic acid (SA) composition of 
porcine milk would be influenced by stage of lactation.
Methods: Up to 250 mL of milk were collected from seven sows at each of three time 
points: day 0 (colostrum), days 7–9 (mature), and days 17–19 (weaning). Colostrum was 
collected within 6 h of farrowing and 3-day intervals were used for mature and weaning 
milk to ensure representative sampling. Milk samples were analyzed for OS profiles by 
Nano-LC Chip–QTOF MS, OS concentrations via HPAEC-PAD, and SA (total and free) 
was assessed by enzymatic reaction fluorescence detection.
results: Sixty unique OSs were identified in porcine milk. Neutral OSs were the most 
abundant at each lactation stage (69–81%), followed by acidic-sialylated OSs (16–29%) 
and neutral-fucosylated OSs (2–4%). As lactation progressed, acidic OSs decreased 
(P =  0.003), whereas neutral-fucosylated (P <  0.001) and neutral OSs (P =  0.003) 
increased throughout lactation. Six OSs were present in all samples analyzed across 
lactation [lacto-N-difucohexaose I (LNDFH-I), 2′-fucosyllactose (2′-FL), lacto-N-fuco-
pentaose I (LNFP-I), lacto-N-neohexaose (LNnH), α1-3,β-4-d-galactotriose (3-Hex), 
3′-sialyllactose (3′-SL)], while LDFT was present only in colostrum samples. Analysis of 
individual OS concentrations indicated differences (P = 0.023) between days 0 and 7. 
Conversely, between days 7 and 18, OS concentrations remained stable with only LNnH 
(P < 0.001) and LNDFH-I (P = 0.002) decreasing over this period. Analysis of free SA 
indicated a decrease (P < 0.001) as lactation progressed, while bound (P < 0.001) and 
total (P < 0.001) SA increased across lactation.
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inTrODUcTiOn
The gastrointestinal tract is known to directly influence physiol-
ogy of the entire organism. Relative to the rest of the body, the 
highest number of immune cells and a diverse microbiome are 
present in the gut. In the developing infant, gut maturation is 
influenced by oligosaccharides (OSs) present in the mother’s 
milk and OS composition of human milk changes throughout 
lactation, which likely has specific physiological implications in 
the developing infant. Piglets are considered a suitable model for 
human infant nutrition due to similarities in the development of 
intestinal physiology and nutrient requirements (1, 2). However, 
very little is known about the OS composition of porcine milk and 
the ways in which these concentrations change across lactation. 
Thus, there is interest in characterizing the bioactive components 
present in porcine milk that could modulate later gastrointestinal 
development, affording a meaningful comparison with human 
and other mammal’s milk composition. By understanding the 
similarities between porcine and human milk OS composition, 
researchers will be able to elucidate how specific OS aid in the 
development of the gastrointestinal tract.
Oligosaccharides are increasingly recognized as bioac-
tive components of milk, and are believed to confer benefits 
throughout neonatal development (3). While the ratios of 
OS present in milk tend to vary among animal species, their 
presence exerts similar physiological effects, regardless of 
the animal species (4). Broadly speaking, functions of OS 
in neonatal development include prophylactically binding 
pathogens, acting as prebiotics for gut microbiota, modulation 
of intestinal and immune system development (5), and enhanc-
ing brain development (6, 7). Glycans present in human milk 
OS can serve as receptors for pathogens, such as rotavirus 
(8), Escherichia coli, Vibrio cholera, and Salmonella fyris (9), 
thereby inhibiting pathogen binding to mucosal surfaces (3). 
The prebiotic effects of OS promote colonization of beneficial 
Bifidobacteria in the neonate (5). As such, Bifidobacteria bind 
to intestinal epithelial cells, and the epithelial cells respond to 
inflammatory stimuli by releasing anti-inflammatory cytokines 
and decreasing release of inflammatory cytokines (10).
Sialic acid (SA)-containing structures are essential in the 
first stages of life for optimal development due to the biological 
processes in which they are involved: inhibition of pathogen 
binding, brain development, and immune system maturation 
(11–13). Sialic acid, both free and when incorporated into other 
compounds, such as sialyllactose (i.e., SA +  lactose) plays an 
important role in immunological defenses of the young animal 
and lowers the risk of infection as gut maturation and microbial 
colonization occur (13, 14). Sialic acid is a main component of 
brain gangliosides that help in neural transmission and storage 
of information (15). Accordingly, SA supplementation in piglets 
has been shown to influence gene expression for neural cell 
adhesion molecules (16) and enhance learning and memory (7). 
Supplementation of sialyllactose increased ganglioside bound SA 
in the corpus callosum of piglets (17). Provided the multitude 
of ways in which SA supplementation influences infant develop-
ment, there is interest in characterizing changes in free and 
bound SA in expressed milk throughout lactation.
While the functions of these molecules are clear, sensitive 
evaluation of the changes in OS profiles and concentrations 
throughout lactation is lacking. Due to their structural diversity 
in both the composing monosaccharides and their linkages, 
the identification and quantification of OS has proven difficult. 
Recent technological developments elevated mass spectrometry 
as one of the most valuable and widely used tools for characteriza-
tion of OS in mammalian milks and other biological samples 
(18–20). Previous studies identified more than 100 OSs in human 
milk and 50 in bovine milk (18, 21, 22). To date, only a few 
studies have evaluated porcine milk OS, with up to 39 different 
OSs being characterized (23–25). The objective of our study was 
to quantify profiles of OS and SA in porcine milk throughout 
lactation to permit direct comparison with published profiles 
found in human milk. We hypothesized that day of lactation 
would impact the OS and SA concentrations of porcine milk, and 
we expand on recent research through identification of additional 
porcine milk OS as well as quantification of OS relative to known 
standards. Thus, findings from the present study may advance 
use of the porcine model for studying pediatric nutrition with 
outcomes, including how the gut microbiome, neurodevelop-
ment, or immunomodulation are influenced by dietary OS.
MaTerials anD MeThODs
animals and Diets
Seven Yorkshire sows from the University of Illinois Imported 
Swine Research Laboratory (ISRL) were bred to Yorkshire 
boars and housed in standard gestation and farrowing crates 
throughout the study. Sows were provided custom gestation and 
lactation diets as described below. Two replicates of sows from 
consecutive farrowing groups were used with 3–4 sows in each 
replicate. Sows were allowed ad libitum access to water and were 
fed according to standard agricultural practices once each day 
(0700 h) during gestation and twice each day (0700 and 1600 h) 
during lactation to maintain body condition. Gestation diets 
were provided through 48 h post farrowing, at which time sows 
conclusion: Concentrations of OS differ between colostrum and mature milk in the pig, 
and SA concentrations shift from free to bound forms as lactation progresses. Our results 
suggest that although porcine milk OS concentration and the number of structures is 
lower than human milk, the OS profile appears to be closer to human milk rather than to 
bovine milk, based on previously published profiles.
Keywords: oligosaccharides, milk, porcine, sialic acid, milk composition
TaBle 1 | Formulated and analyzed composition of gestation and lactation 
diets.a
ingredient, g/kg gestation lactation
Ground corn 785.0 652.0
Molassed dried sugar beet pulp 70.0 65.0
Soy protein isolateb 60.0 118.0
Cornstarch 39.7 101
Dicalcium phosphate 20.0 20.0
Corn oil 10.0 30.0
Limestone 7.5 6.5
Vitamin and mineral premixc 3.0 3.0
Choline chlorided 3.0 2.4
Bacitracine 0.0 2.1
dl-Met 1.5 0.0
l-Trp 0.3 0.0
Formulated composition, mg/kg
Choline 1,887 1,591
Folate 2.80 2.60
Analyzed composition
Dry matter, % 90.6 88.8
g/100 g of dry matter
Organic matter 95.6 95.6
Crude protein 13.7 18.3
Crude fat 2.69 2.58
Amino acids
Lys 0.64 0.99
Met 0.42 0.25
Cys 0.23 0.25
Arg 0.75 1.11
Ile 0.54 0.77
Leu 1.42 1.57
Val 0.70 0.87
Phe 0.66 0.91
Thr 0.46 0.66
Trp 0.15 0.21
aExperimental diets were formulated to meet or exceed nutrient and ME requirements 
for sows (26).
bArdex F, Archer Daniels Midland, Decatur, IL, USA.
cProvided per kilogram of complete diet: Ca, 318 mg (CaCO3); Zn, 125 mg (ZnSO4 
H2O); Fe, 128 mg (FeSO4·H2O); Mn, 60 mg (MnSO4·H2O); Cu, 10.2 mg (CuSO4·5H2O); 
I, 1.3 mg (ethylenediamine dihydroiodide); Se, 0.3 mg (50% Se yeast, 50% Na2SeO3); 
vitamin A, 11,160 IU (retinyl acetate); vitamin D, 2,214 IU (cholecalciferol); vitamin 
E, 66 IU (DL-α-tocopherol acetate); vitamin K, 1.4 mg (menadione nicotinamide 
bisulfite); thiamine, 0.2 mg (thiamine mononitrate); riboflavin, 6.6 mg; niacin, 44 mg 
(nicotinamine); pantothenic acid, 24 mg (D-Ca pantothenate); pyridoxine, 0.2 mg 
(pyridoxine·HCl); biotin, 0.4 mg; folic acid, 1.6 mg; vitamin B12, 0.03 mg.
dCholine chloride 60%, Balchem, New Hampton, NY, USA.
eBMD60, Alpharma Inc., Bridgewater, NJ, USA.
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were provided lactation diets until 19  days of lactation. Corn 
and soy-protein isolate-based diets were formulated to meet 
requirements for all nutrients (Table  1) (26). A prophylactic 
antibiotic (BMD60, Alpharma, Bridgewater, NJ, USA) was added 
to sow diets according to manufacturer specifications starting 
on day 94 of gestation and continuing throughout lactation to 
prevent Clostridium perfringens-induced diarrhea in piglets. All 
animal care and experimental procedures were in accordance 
with the Guide for the Care and Use of Laboratory Animals and 
approved by the Institutional Animal Care and Use Committee 
of the University of Illinois.
Milk collection
Milk samples were collected from each sow at three time-points 
throughout lactation. Colostrum was collected within 6  h of 
farrowing. To ensure representative samples of mature and wean-
ing milk, samples were collected over 3-day collection periods, 
i.e., days 6–8 and days 17–19. Approximately 250  mL of milk 
were collected per sow at each time period. To facilitate milk let-
down, piglets were removed from the sow for 1 h and placed in 
an adjacent, empty farrowing crate with access to supplemental 
heat and water. An intramuscular injection of oxytocin (2 mL, 
OxoJect, Henry Schein Animal Health, Dublin, OH, USA) was 
administered after 1 h without piglets, and milk was manually 
expressed into 50 mL conical tubes and stored at −20°C. Prior 
to analysis, milk samples were thawed, combined to create a 
homogeneous milk sample for each sow, and divided into ali-
quots; only one freeze–thaw process occurred prior to nutrient 
quantification procedures.
Materials
Acetonitrile (ACN), formic acid (FA), trifluoroacetic acid (TFA), 
sodium hydroxide (NaOH), sodium chloride (NaCl), and sulfu-
ric acid (H2SO4) were obtained from Thermo Fisher Scientific 
(Waltham, MA, USA); sodium acetate (NaAc) was purchased 
from Sigma-Aldrich (St Louis, MO, USA). All solvents were MS 
grade. OS standards for lacto-N-difucohexaose I (LNDFH-I), 
2′-fucosyllactose (2′-FL), lacto-N-fucopentaose I (LNFP-I), 
lacto-N-tetraose (LNT), lacto-N-neotetraose (LNnT), lacto-N-
neohexaose (LNnH), N-acetylgalactosaminyllactose, α1-3,β-4-
d-galactotriose (3-Hex), 3′-sialyllactose (3′-SL), 6′- sialyllactose 
(6′-SL), and 6′-sialyl-N-acetyllactosamine (6′-SLN) were pur-
chased from V-Labs Inc. (Covington, LA, USA), while LNH and 
LDFT standards were purchased from Prozyme Inc. (Hayward, 
CA, USA). The water used in all experiments was nanopure 
(18.2 ohms).
Oligosaccharide isolation and Purification
Oligosaccharides were isolated and purified according to a pre-
viously published method (27) with the following modifications: 
the crude OS extract was purified by solid-phase extraction using a 
Porous Graphitized Carbon microplate (PGC-SPE; Glygen Corp, 
Columbia, MD, USA), activated with three column volumes of 
80% ACN, 0.1% TFA (v/v), and equilibrated with three column 
volumes of nanopure water. The OS-rich solution was loaded 
onto the cartridge, and salts were removed by washing with 10 
column volumes of nanopure water. The OSs were then eluted 
with a solution of 40% ACN and 0.1% TFA (v/v) in water and 
dried in a speed vacuum centrifuge (miVac Quattro, Genevac, 
Ipswich, UK) at 35°C. Purified OSs were re-dissolved in 500 μL of 
nanopure water, sonicated for 10 min, and appropriately diluted 
for Nano-LC Chip–QTOF MS and HPAEC-PAD analyses.
Oligosaccharides Profiling by Mass 
spectrometry nano-lc chip–QTOF-Ms
Nano-LC Chip–QTOF-MS/MS analysis was performed with 
an Agilent 6520 accurate-mass Quadrupole-Time-of-Flight 
(Q-TOF) LC/MS with a microfluidic nano-electrospray chip 
containing an enrichment and an analytical column packed 
with porous graphitized carbon (Agilent Technologies, Santa 
Clara, CA, USA). Nano-LC QTOF MS/MS parameters were as 
described previously (28) and a targeted porcine milk OS library 
TaBle 2 | Qualitative profiles and relative abundances of oligosaccharides (Os) in porcine milk throughout lactation.
# composition1 Formula exact mass
(exact)
retention 
Time, min
Type2 relative abundance  
(%) by Day of lactation3
±seM P-value Presence in 
human milk4
0 7 18
1 2_0_1_0_0 C18 H32 O15 488.1738 12.11 NF 0.33a 2.37b 1.87b 0.270 <0.0001 
2 2_0_1_0_0 C18 H32 O15 488.1723 14.37 NF 0.40 0.36 0.41 0.055 0.5507 
3 2_0_1_0_0 C18 H32 O15 488.1737 15.62 NF 0.71 0.71 0.74 0.106 0.9579 
4 3_0_0_0_0 C18 H32 O16 504.1694 12.40 N 4.31a 1.43b 1.07b 0.559 0.0011 
5 3_0_0_0_0 C18 H32 O16 504.1690 13.02 N 3.55a 1.91b 2.03b 0.366 <0.0001 
(Continued)
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was built using the OS identified by MS/MS; each sample was 
analyzed in triplicate.
Composition of eluted OS is listed as a set of the five indi-
vidual monomers composing the OS using the following iden-
tification nomenclature: Hex_HexNAc_Fuc_Neu5Ac_Neu5Gc. 
Abbreviations for the components are as follows: Hex, hexose (glu-
cose or galactose); HexNAc, N-acetylhexososamine; Fuc, fucose; 
Neu5Ac, N-acetylneuramic acid; Neu5Gc, N-glycolylneuramic 
acid. The number of each individual monomer present within 
an identified or quantified OS is represented using the afore-
mentioned nomenclature. It should be noted that the analysis 
by Nano-LC Chip–QTOF MS separated multiple isomers for 
each OS; however, here we indicate the relative percentage of 
composition 3_1_0_0_0 (3 Hex, 1 HexNAc) as the sum of LNT 
and LNnT. Similarly, the relative percentage of composition 
4_2_0_0_0 (4 Hex, 2 HexNAc) was the sum of LNH and LNnH 
due to close eluting times of the isomer pairs (i.e., co-elution).
Oligosaccharide Quantification  
by hPaec-PaD
Quantification of eight neutral (LNDFH, LDFT, 2′-FL, LNFP-I, 
LNT, LNnT, N-acetylgalactosaminyllactose, and 3-Hex) and 
3 acidic (6′-SLN, 6′-SL, and 3′-SL) OSs was carried out using 
high-performance anion-exchange chromatography with pulsed 
amperometric detection (HPAE-PAD ICS-5000; Thermo Fisher 
Scientific, Waltham, MA, USA). Diluted OS solutions were 
filtered through a 0.22  μm membrane and injected using a 
25 μL loop. Chromatographic separation was carried out on a 
CarboPac PA200 analytical column (3 mm × 250 mm; Dionex, 
Sunnyvale, CA, USA) and a CarboPac PA200 guard column 
(3 mm × 50 mm; Dionex, Sunnyvale, CA, USA) with 0.5 mL/
min elution and a non-isocratic gradient: 0–10  min 50% B, 
10–50  min 45% B – 10% C. The column was equilibrated for 
5 min with 10% B followed by 10 min with 50% B. Solvent A was 
deionized water, solvent B 200 mM NaOH, and solvent C was 
100 mM NaAc in 100 mM NaOH. Quantification was assessed 
by external calibration using a mixture of all OS standards rang-
ing from 0.0001 to 0.03 g/L.
Quantification of sialic acid by enzymatic 
reaction and Fluorescence Detection
To evaluate total SA content, an acid hydrolysis was performed: 
200 μL of sample was mixed with 800 μL of 0.05 M H2SO4, heated 
(60 min at 80°C), cooled to room temperature and centrifuged 
(13,000 × g for 30 min at 4°C). For free SA determination, 1 mL 
of sample was centrifuged (13,000 ×  g for 30  min at 4°C), the 
aqueous phase was collected, and 400 μL of the supernatant was 
purified by solid phase extraction using strong anionic exchange 
cartridges (OnGuard II-A; Dionex, Sunnyvale, CA, USA) that 
had been previously activated with 10 mL deionized water. After 
sample loading, each cartridge was washed with 10 mL of distilled 
water and SA was eluted with 10 mL of 100 mM NaCl. Dried sam-
ples were reconstituted in 500 μL of deionized water, vortexed, 
and sonicated to assure complete solubilization. SA (expressed 
as Neu5AC) concentrations were assessed to determine free 
and total SA in each sample using an enzymatic commercial kit 
with fluorescence detection (ab83375; Abcam, Cambridge, UK) 
as described by the manufacturer. Subsequently, the quantity of 
bound SA was calculated as the difference between total and free 
SA concentrations.
statistical analysis
A one-way repeated measures ANOVA was performed using the 
MIXED procedure of SAS 9.3 (SAS Institute, Cary, NC, USA) to 
evaluate differences in the relative proportion of OS and indi-
vidual concentrations of OS and SA in porcine milk throughout 
lactation. Day of lactation served as the repeated measure, and 
an HSD-Tukey adjustment was applied during the post hoc data 
analysis. Sow served as the experimental unit for all analyses. 
Prior to statistical analysis, normality and homoscedasticity 
of the data were checked using the Kolmogorov–Smirnov and 
Levene tests, respectively; all data were normally distributed and 
no outliers were identified. Data are presented as least squares 
means for each lactation time-point. Statistical significance was 
considered when P < 0.05.
resUlTs
Oligosaccharide Profiling by Mass 
spectrometry nano-lc chip–QTOF Ms
Sixty OSs (including isomers and anomers) were identified and 
confirmed by Nano-LC Chip–Q-TOF MS/MS in this study 
(Table 2). Six OSs comprised 60% of the total (2 Hex-1 Neu5Ac 
or sialyllactose; 3 Hex-1 HexNAc; 3 Hex; 4 Hex-1 HexNAc; 4 
Hex-2 HexNAc; and 4 Hex-2 HexNAc-1 Neu5Ac), with 4 Hex-2 
HexNAc (25–33%) being the most abundant at each stage of lacta-
tion. 3′-Sialyllactose was the second most abundant in colostrum, 
accounting for 8% of the total OS.
# composition1 Formula exact mass
(exact)
retention 
Time, min
Type2 relative abundance  
(%) by Day of lactation3
±seM P-value Presence in 
human milk4
0 7 18
6 3_0_0_0_0 C18 H32 O16 504.1690 13.38 N 6.54a 2.74b 2.90b 0.671 0.0007 
7 3_0_0_0_0 C18 H32 O16 504.1692 14.41 N 2.48a 2.06b 2.05b 0.247 0.0299 
8 3_0_0_0_0 C18 H32 O16 504.1696 15.66 N 0.58a 0.80a 1.54b 0.212 0.0002 
9 3_0_0_0_0 C18 H32 O16 504.1688 16.45 N 0.30a 0.27a 0.51b 0.082 0.0200 
10 1_0_0_1_0 C18 H32 O15 470.1508 15.78 A 0.01 0.07 0.22 0.131 0.5029 
11 2_0_0_1_0 C23 H39 N O19 633.2118 18.30 A 1.65 1.09 1.60 0.273 0.3404 
12 2_0_0_1_0 C23 H39 N O19 633.2117 23.37 A 9.73 5.98 4.76 1.610 0.0816 
13 1_1_0_1_0 C25 H42 N2 O19 674.2374 16.77 A 0.25a 0.05b 0.04b 0.025 <0.0001 
14 1_1_0_1_0 C25 H42 N2 O19 674.2377 18.31 A 1.16a 0.21b 0.14b 0.105 <0.0001 
15 1_1_0_1_0 C25 H42 N2 O19 674.2368 22.94 A 0.29a 0.01b 0.00b 0.028 <0.0001 
16 3_1_0_0_0 C26 H45 N O21 707.2477 15.23 N 1.07a 0.69b 0.50b 0.087 0.0007 
17 3_1_0_0_0 C26 H45 N O21 707.2478 16.00 N 0.99 0.53 0.88 0.307 0.5746 
18 3_1_0_0_0 C26 H45 N O21 707.2484 17.14 N 6.89 4.90 5.68 1.404 0.6366 
19 3_1_0_0_0 C26 H45 N O21 707.2477 21.64 N 0.90a 0.97a 0.56b 0.102 0.0236 
20 2_2_0_0_0 C28 H48 N2 O21 748.2742 15.28 N 0.65a 0.33b 0.26b 0.082 0.0034 
21 3_0_0_1_0 C29 H49 N O24 795.2641 24.11 A 0.03 0.29 0.45 0.162 0.2025 
22 3_0_0_1_0 C29 H49 N O24 795.2641 25.19 A 0.35a 0.77ab 1.06b 0.182 0.0335 
23 3_0_0_1_0 C29 H49 N O24 795.2644 25.80 A 0.39a 0.63ab 0.87b 0.099 0.0051 
24 4_1_0_0_0 C32 H55 N O26 869.3013 19.69 N 5.36 7.37 7.11 0.672 0.1088 
25 4_1_0_0_0 C32 H55 N O26 869.3012 20.70 N 5.43 7.69 7.44 1.076 0.2922 
26 4_1_0_0_0 C32 H55 N O26 869.3005 27.54 N 1.16 2.14 1.93 0.384 0.1309 
27 3_2_0_0_0 C34 H58 N2 O26 910.3274 18.51 N 0.28 0.22 0.65 0.249 0.4526 
28 3_2_0_0_0 C34 H58 N2 O26 910.3288 19.08 N 0.56 1.05 1.06 0.361 0.5082 
29 3_2_0_0_0 C34 H58 N2 O26 910.3286 19.39 N 1.05 1.11 1.58 0.680 0.8237 
30 3_1_0_1_0 C37 H62 N2 O29 998.3431 24.73 A 0.36 0.09 0.30 0.129 0.2926 
31 3_1_0_1_0 C37 H62 N2 O29 998.3457 28.69 A 1.73a 0.31b 0.06b 0.131 <0.0001 
32 3_1_0_1_0 C37 H62 N2 O29 998.3448 26.35 A 0.10 0.11 0.07 0.025 0.3424 
33 4_1_1_0_0 C38 H65 N O30 1015.3573 15.38 NF 0.10a 0.02b 0.00b 0.024 0.0106 
34 4_2_0_0_0 C40 H68 N2 O31 1072.3836 21.64 N 18.71a 30.75ab 29.66b 3.038 0.0179 
35 4_1_0_1_0 C43 H72 N2 O34 1160.3979 27.14 A 0.29a 1.12b 0.70b 0.163 0.0005 
36 4_1_0_1_0 C43 H72 N2 O34 1160.3982 27.54 A 0.78a 2.04b 1.15a 0.340 0.0009 
37 4_2_0_1_0 C51 H85 N3 O39 1363.4791 26.13 A 7.03 6.19 2.73 1.324 0.0704 
38 4_2_0_1_0 C51 H85 N3 O39 1363.4783 28.93 A 3.12a 0.12b 0.03b 0.286 <0.0001 
39 1_0_0_1_0 C17 H29 N O14 471.1616 11.70 A 0.01a 0.14ab 0.21b 0.043 0.0149 
40 1_1_1_0_0 C20 H35 N O15 529.1994 13.18 NF 0.15a 0.13a 0.06b 0.025 0.0158 
41 1_1_1_0_0 C20 H35 N O15 529.1993 13.73 NF 0.12a 0.05b 0.03b 0.022 0.011 
42 2_1_0_0_0 C20 H35 N O16 545.1953 11.35 N 0.55a 1.02ab 1.94b 0.335 0.0054 
43 2_1_0_0_0 C20 H35 N O16 545.1954 12.05 N 0.60a 1.48ab 2.55b 0.590 0.0052 
44 2_1_0_0_0 C20 H35 N O16 545.1954 12.98 N 1.46a 3.31b 4.66b 0.482 0.0004 
45 2_1_0_0_0 C20 H35 N O16 545.1953 13.96 N 0.35a 0.77ab 1.88b 0.320 0.0102 
46 2_1_0_0_0 C20 H35 N O16 545.1953 14.38 N 0.30a 0.77b 0.72ab 0.226 0.0290 
47 2_1_0_0_0 C20 H35 N O16 545.1951 15.70 N 0.12 0.21 0.34 0.099 0.2928 
48 4_0_0_0_0 C24 H42 O21 666.2211 2.42 N 0.28a 0.33ab 0.75b 0.109 0.0147 
49 4_0_0_0_0 C24 H42 O21 666.2215 12.72 N 0.16 0.18 0.10 0.044 0.338 
50 4_0_0_0_0 C24 H42 O21 666.2212 19.93 N 0.16 0.11 0.09 0.023 0.065 
51 2_1_1_0_0 C26 H45 N O20 691.2525 12.97 NF 0.00a 0.18b 0.10ab 0.034 0.0048 
52 2_1_0_1_0 C31 H52 N2 O24 836.2902 13.79 A 0.01 0.01 0.18 0.108 0.4052 
53 2_1_0_1_0 C31 H52 N2 O24 836.2894 14.96 A 1.02 0.11 0.65 0.409 0.2439 
54 2_1_0_1_0 C31 H52 N2 O24 836.2899 22.71 A 0.11 0.10 0.21 0.078 0.5575 
55 3_1_1_0_0 C32 H55 N O25 853.3067 15.80 NF 0.35a 0.06b 0.07b 0.054 0.0018 
56 5_1_0_0_0 C38 H65 N O31 1031.3523 22.80 N 0.15 0.07 0.04 0.031 0.0571 
57 3_3_0_0_0 C42 H71 N3 O31 1113.4093 22.32 N 1.15a 0.08b 0.02b 0.130 <0.0001 
58 3_3_0_0_0 C42 H71 N3 O31 1113.4092 20.12 N 3.13a 1.18b 0.67b 0.392 0.0009 
59 7_0_0_0_0 C42 H72 O36 1152.3789 17.83 N 0.01 0.02 0.01 0.007 0.4861 
60 3_2_0_1_0 C45 H75 N3 O34 1201.4255 25.60 A 0.18 0.17 0.10 0.061 0.4814 
1Composition (in order): Hex_HexNAc_Fuc_Neu5Ac_Neu5Gc. Hex, hexose (glucose or galactose); HexNAc, N-acetylgalactosamine; Fuc, fucose; Neu5Ac, N-acetylneuraminic acid; 
Neu5Gc, N-glycolylneuraminic acid.
2Type of oligosaccharide: N, neutral OS; NF, neutral-fucosylated OS; A, acidic OS.
3Relative abundance expressed as a mean of seven different porcine milk samples for each time-point analyzed in triplicate. Data expressed relative to the total amount of 
oligosaccharides detected in each individual porcine milk sample. Italicized means are not statistically different than 0 (P < 0.05). abMeans without a common superscript letter within 
a row differ (P < 0.05).
4Qualitative profile comparison between porcine and human milk oligosaccharides (21, 22).
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TaBle 2 | continued
FigUre 2 |  Oligosaccharide quantification by hPae-PaD (expressed 
as mg/l) in porcine milk. Total OS concentrations decreased (P < 0.0001) 
across lactation. Individual differences were observed for six quantified OS, 
with all OS exhibiting changes in concentration (P < 0.05) throughout 
lactation. The following OS had concentrations below detectable limits for the 
specified number of sows (n) for at least one analyzed time point: 2′FL 
(n = 4), LNFP-I (n = 5), 3-Hex (n = 1), 3-SL (n = 1). Means with an * are not 
statistically different than 0. abcIndicate statistical differences among time of 
milk collection during the lactation period, where means that do not share a 
common superscript letter differ (P < 0.05, HSD-Tukey Test). Abbreviations: 
LNDFH-I, lacto-N-difucohexaose I; 2′-FL, 2′-fucosyllactose; LNFP-I, 
lacto-N-fuctopentaose I; 3-Hex, α1-3,β1-4-d-galactotriose; 3′-SL, 
3′-sialyllactose; LNnH, lacto-N-neohexaose.
FigUre 1 |  Oligosaccharide distribution in porcine milk. Results are 
expressed as the average of the relative abundance (%) of OS found in 
porcine milk from seven sows throughout the lactation period. Neutral, 
neutral-fucosylated, and acidic OS distributions exhibited changes by day 
(P < 0.05) throughout lactation. a,bIndicate statistical differences among time 
of milk collection during the lactation period, where means that do not share 
a common superscript letter differ (P < 0.05, HSD-Tukey Test).
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Mature milk contained mainly neutral non-fucosylated OS, 
4 Hex-2 HexNAc, and 3-Hex comprising more than 35% of the 
total OS. Neutral OSs were the most abundant at each lactation 
stage (69–81%), followed by acidic-sialylated OS (16–29%) 
and neutral-fucosylated OS (2–4%) (Figure  1). As lactation 
progressed, a shift in the type of OS abundances was apparent, 
exhibited as a decrease (P = 0.0026) in acidic OS and an increase 
in neutral-fucosylated (P < 0.0001) and neutral (P = 0.0031) OS 
from the beginning to the end of lactation.
Oligosaccharide absolute Quantification 
by hPaec-PaD
Eight neutral OS (LNDFH-I, LDFT, 2′-FL, LNFP-I, LNT, LNnH, 
2Hex-1HexNAc, and 3 Hex) and three acidic (6′-SLN, 6′-SL, and 
3′-SL) were quantified using reference standards. Six OSs were 
present in all the samples analyzed across lactation (LDFH-I, 
2′-FL, LNFP-I, LNnH, 3 Hex, 3′-SL; Figure 2), while LDFT was 
present only in colostrum samples (data not shown). The OS 
LNT, 2Hex-1HexNAc, 6′-SLN, and 6′-SL were not quantifiable 
in any sample due to concentrations being below detectable 
levels.
Total quantified OS concentrations in porcine milk decreased 
(P < 0.0001) throughout lactation (Figure 2). Differences across 
lactation were also observed for LNDFH-I (P < 0.0001), 2′-FL 
(P <  0.0001), LNFP-I (P <  0.0001), 3-Hex (P =  0.0157), 3′-SL 
(P < 0.0001), and LNnH (P < 0.0001). Further analysis indicated 
decreases (P < 0.001) in LNFP-I concentrations at each lactation 
point. Both 2′FL and 3-Hex increased (P < 0.05) from days 0 to 
7 but remained constant from days 7 to 18. Conversely, LNFP-I 
and 3′-SL indicated decreases (P < 0.001) from days 0 to 7 while 
remaining stable from days 7 to 18. A decrease in concentration 
was observed for LNnH (P < 0.001) and LNDFH-I (P = 0.002) from 
days 7 to 18. These results match relative abundance findings in 
the OS profiling, where sialylated OS decreased throughout lacta-
tion and fucosylated OS showed a small, but significant, increase. 
In general, the most abundant OSs were LNnH (~50 mg/L) and 
3′-SL (~30 mg/L), followed by 3-Hex (~20 mg/L), when averaged 
over lactation.
Total and Free sialic acid quantification by 
enzymatic reaction – Fluorescence 
Detection
The concentrations of total, free, and bound SA were deter-
mined using an enzymatic reaction with fluorescence detection 
(Figure  3). Overall, differences (P  <  0.0001) were observed 
between lactation time-points for each of free, bound, and total 
SA. Free SA concentrations decreased (P = 0.0126) from days 0 to 
7, but remained constant from days 7 to 18, whereas bound and 
total SA concentrations increased (P < 0.0001) at each lactation 
time-point. The ratio of free-to-total SA decreased (P < 0.0001) 
from days 0 to 7, but this ratio did not change from days 7 to 18. 
Conversely, the ratio of bound-to-total SA increased (P < 0.0001) 
from days 0 to 7, but remained constant from days 7 to 18. The 
ratio of free-to-bound SA indicated a decrease (P < 0.0001) across 
lactation, where the proportion of free-to-bound SA decreased 
(P = 0.0012) from days 0 to 7 and remained constant from days 
7 to 18.
FigUre 3 |  Total, free, and bound sialic acid (sa) concentration (expressed as mg neuac/l) in porcine milk. Bound SA was determined from the 
difference between total and free SA. (a) Concentrations of free SA decreased (P < 0.0001), whereas bound and total SA increased (P < 0.0001) across lactation. 
(B) An increase (P < 0.0001) was observed for the ratio of bound-to-free SA from days 0 to 7 and remained constant after day 7. (c) The ratio of free-to-total SA 
decreased (P < 0.0001) from days 0 to 7 and then remained constant from days 7 to 18. (D) The ratio of free-to-bound SA decreased (P < 0.0001) from days 0 to 7 
and remained constant from days 7 to 18. Means with an asterisk (*) are not statistically different than 0 (P < 0.05). abcIndicate statistical differences among time of 
milk collection during the lactation period, where means that do not share a common superscript letter differ (P < 0.05, HSD-Tukey Test).
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DiscUssiOn
Oligosaccharides are a class of molecules that have gained con-
siderable attention because of the biological processes in which 
they impact the first stages of life (5). Because the piglet is a 
widely used model for human infant nutrition, it is necessary to 
understand how the OS composition of porcine milk compares to 
human milk. By characterizing these similarities and the changes 
that occur across lactation, researchers will be able to use this 
knowledge to aid in development of future gut development stud-
ies. In the present study, porcine milk was analyzed to identify the 
OS variation during lactation and, when availability of known 
standards allowed, quantify the most abundant OS compounds. 
Additionally, free, bound, and total SA concentrations were ana-
lyzed to quantify concentrations and relative changes in porcine 
milk throughout lactation.
Sixty OSs (including isomers and anomers) were identified 
in porcine milk during the first 18 days of lactation by Nano-LC 
Chip–Q-TOF MS, with 24 structures matching those identified 
in human milk (21, 22). The total number of OSs identified is 
within the range described previously (23, 25), though a num-
ber of novel isoforms were identified in this study, suggesting 
potential diversity due to genetic or environmental influences. 
However, the relative amount of neutral OS identified in the 
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present study (73–78%) is higher than what was previously 
determined for porcine colostrum (20%) (23, 25). Also, the 
percentage of fucose-containing OS increased as lactation pro-
gressed, while sialylated OS decreased; to our knowledge, this 
is the first report of a simultaneous increase of fucosylated OS 
and a decrease in sialylated OS. Interestingly, the present study 
did not detect any OS containing Neu5Gc, which suggest the 
OS profile of porcine milk more closely matches that of human 
milk than milk from other domestic animals, including bovine 
milk (29). Similar to what is reported for human milk, only a few 
OS contributed to the majority of the OS abundance in porcine 
milk. Human milk is considered unique as it contains type I 
OS [LNT, LNFP-I, lacto-N-fucopentaose II (LNFP-II), and 
LNDFH-I], none of which have ever been identified in bovine 
milk (4). Due to the proximity of elution times and the lack of 
MS-grade standards, it was not possible to distinguish among 
LNH/LNnH and LNT/LNnT isomers by Nano-LC Chip QTOF 
MS, but LNDFH-I was unambiguously detected in porcine 
milk and LNnH was successfully quantified using HPAE-PAD. 
Considering the lack of Neu5Gc, the contribution of just a few 
major OS to the overall OS present, the increase of fucosylation 
during lactation and the presence of LNDFH-I, evidence from 
this study suggests that porcine milk is closer in OS composition 
to human milk than previously established.
Quantification of OSs is generally limited to a few structures 
due to the paucity of commercial standards, which greatly 
impedes quantification of the diverse set of compounds that can 
be identified by Nano-LC Chip–Q-TOF MS. In the present study, 
eight neutral and three acidic OSs, which are found in human 
and/or bovine milk, were accurately quantified. The general 
trends in quantified OS match with observations of the global 
profiling by Nano-LC Chip–QToF MS, where sialylated OS 
decreased, and fucosylated OS increased, in abundance during 
lactation. The higher abundance of fucosylated versus sialylated 
OS structures places porcine milk OS (albeit in lower concentra-
tions) as structurally closer to OS profiles found in human milk, 
rather than bovine milk. Additionally, the conspicuous absence 
of Neu5Gc-containing OS and the simultaneous presence of 
typical human milk OS, such as LNDFH-I, places porcine milk 
far closer to human milk than previously thought. Although 
porcine milk appears to closely resemble human milk composi-
tion, as stated above, there are some characteristics that tend 
to align more closely with bovine milk, namely individual OS 
concentrations in porcine milk tended to be lower than those 
found in human milk (30, 31) and rather similar to those found 
in bovine milk (32–34) with total OS concentrations decreasing 
throughout lactation.
Sialic acid is present in mammals’ biological fluids and 
tissues, contributing to the formation of complex structures, 
such as glycolipids or glycoproteins. Only 5% of the total SA 
typically exists in the free or unbound form (29). Following a 
similar trend to overall OSs, the total and free SA concentra-
tions of porcine milk were lower than what has been described 
for human milk, yet similar to that found in bovine milk 
(15  mg/L) (35). However, it is important to note that there 
are relatively few studies that have evaluated SA concentra-
tions of bovine milk, and variability exists in factors, including 
maternal breed (wide range of concentrations ranging from 15 
to 500 mg/L) and methodologies employed for quantification 
(e.g., colorimetric vs. HPLC). Concentrations of free SA quanti-
fied in the present study appears high (i.e., free SA represented 
33% of total quantified SA on day 0), though this ratio rapidly 
changed over the course of lactation, with free SA accounting 
for only 7.4% of total SA at the end of lactation. This dynamic 
in the form of SA throughout lactation suggests that porcine 
milk more closely matches human than bovine milk, which 
typically contain roughly 5% of the total SA acid as the free 
form. Notably, our results were lower than those described for 
human colostrum (35 and 1500 mg/L for free and total, respec-
tively) (36, 37) and bovine milk (15–500  mg/L of total SA) 
(35, 38). Additionally, the ratio of free-to-bound SA appeared 
to continually decrease throughout lactation, suggesting that 
more SA was being incorporated into other compounds. The 
majority of SA present in the body, most notably the brain, is 
in a bound form (13); thus, the increase in bound SA in milk 
is of interest in understanding how this might confer benefits 
in neurodevelopment.
At the first stages of life, enzymes involved in SA synthesis and 
incorporation into other structures are not mature or active. In 
quantitative terms, this developmental insufficiency may increase 
the dietary SA requirement to maintain biological processes and 
ensure optimal development. As infant enzyme systems support-
ing SA production mature throughout the lactation period, their 
dietary requirements for free SA decrease, hence the biological 
basis for milk SA to decrease throughout lactation (35–37). The 
values for free SA reported in our study are in agreement with the 
literature, where a decrease was observed throughout lactation. 
Interestingly, our results also show an increase of total SA and 
sialylated structures over lactation, which was not previously 
reported. Taken together, these results might suggest that as 
lactation progresses, SA is incorporated into different structures 
rather than remaining free in the milk.
The present work expands on previous work in analysis of 
porcine OS by characterizing additional novel OS present in 
porcine milk, while also quantifying changes in SA across lacta-
tion. Moreover, this study suggests that although porcine milk 
OS concentration and the number of structures is lower than 
human milk, the OS profile appears to be closer to human milk 
rather than to bovine milk. Much of the similarities are based on 
the increased proportion of fucosylated OS during lactation and 
the ability of sows to synthetize OS commonly present in human 
milk. These findings support the use of pigs as an ideal model 
for studies on human nutrition, not only because of the striking 
similarities in intestinal, immune system, and brain development 
but also due to their similarities in milk OS composition.
aUThOr cOnTriBUTiOns
RD, CG, SJ, LA, AM, BB, and MC were involved in project 
conceptualization. CG, SJ, LA, and AM were involved in daily 
project operations and data collection. JS and DB were respon-
sible for analytical procedures. All authors were involved in data 
analysis, interpretation, and have reviewed and approved this 
manuscript.
9Mudd et al. Oligosaccharide Characterization of Porcine Milk
Frontiers in Nutrition | www.frontiersin.org September 2016 | Volume 3 | Article 39
acKnOWleDgMenTs
The authors would like to thank the University of Illinois 
Imported Swine Research Laboratory staff for their contributions 
to the preparation and follow-through of the animal phase of this 
study. We would also like to thank Diana Flanigan from Mead 
Johnson Nutrition Analytical Sciences for her role in sample 
preparation, storage, and handling.
FUnDing
This work was partially supported by the United States Department 
of Agriculture National Institute of Food and Agriculture, Hatch 
project 1009051. The USDA funders had no role in study design, 
data collection and analysis, decision to publish, or preparation 
of the manuscript. This project was also partially funded by Mead 
Johnson Pediatric Nutrition Institute.
reFerences
1. Calder PC, Krauss-etschmann S, de Jong EC, Dupont C, Frick JS, Frokiaer H, 
et al. Workshop report early nutrition and immunity – progress and perspec-
tives. Br J Nutr (2006) 44:774–90. doi:10.1079/BJN20061917 
2. Jacobi SK, Odle J. Nutritional factors influencing intestinal health of the 
neonate. Adv Nutr (2012) 3(5):687–96. doi:10.3945/an.112.002683.mucosal 
3. Newburg DS, Ruiz-palacios GM, Morrow AL. Human milk glycans protect 
infants against enteric pathogens. Annu Rev Nutr (2005) 25:37–58. doi:10.1146/
annurev.nutr.25.050304.092553 
4. Urashima T, Asakuma S, Leo F, Fukuda K, Messer M, Oftedal OT. The pre-
dominance of type I oligosaccharides is a feature specific to human breast 
milk. Adv Nutr (2012) 3:473–82. doi:10.3945/an.111.001412.473S 
5. Smilowitz JT, Lebrilla CB, Mills DA, German JB, Freeman SL. Breast milk oli-
gosaccharides: relationships in the neonate. Annu Rev Nutr (2014) 34:143–9. 
doi:10.1146/annurev-nutr-071813-105721 
6. Schengrund C. Gangliosides: glycosphingolipids essential for normal neural 
development and function. Trends Biochem Sci (2015) 40(7):397–406. 
doi:10.1016/j.tibs.2015.03.007 
7. Wang B, Yu B, Karim M, Hu H, Sun Y, Mcgreevy P, et al. Dietary sialic acid 
supplementation improves learning and memory in piglets. Am J Clin Nutr 
(2007) 85(2):561–9. 
8. Huang P, Xia M, Tan M, Zhong W, Wei C, Wang L, et al. Spike protein VP8* 
of human rotavirus recognizes histo-blood group antigens in a type-specific 
manner. J Virol (2012) 86(9):4833–43. doi:10.1128/JVI.05507-11 
9. Coppa GV, Zampini L, Galeazzi T, Facinelli B, Ferrante L, Capretti R, et al. 
Human milk oligosaccharides inhibit the adhesion to caco-2 cells of diarrheal 
pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris. Pediatr Res 
(2006) 59(3):377–82. doi:10.1203/01.pdr.0000200805.45593.17 
10. Chichlowski M, De Lartigue G, German B, Raybould H, Mills D. Bifidobacteria 
isolate from infants and cultured on human milk oligosaccharides affect 
intestinal epithelial function. J Pediatr Gastroenterol Nutr (2012) 55(3):321–7. 
doi:10.1097/MPG.0b013e31824fb899.Bifidobacteria 
11. Ryan JM, Rice GE, Mitchell MD. The role of gangliosides in brain development 
and the potential benefits of perinatal supplementation. Nutr Res (2013) 
33(11):877–87. doi:10.1016/j.nutres.2013.07.021 
12. Salcedo J, Barbera R, Matencio E, Alegría A, Lagarda MJ. Gangliosides and 
sialic acid effects upon newborn pathogenic bacteria adhesion: an in  vitro 
study. Food Chem (2013) 136(2):726–34. doi:10.1016/j.foodchem.2012.08.078 
13. Wang B, Brand-Miller J. The role and potential of sialic acid in human nutri-
tion. Eur J Clin Nutr (2003) 57(11):1351–69. doi:10.1038/sj.ejcn.1601704 
14. Chichlowski M, German J, Lebrilla C, Mills D. The influence of milk oli-
gosaccharides on microbiota of infants: opportunities for formulas. Annu 
Rev Food Sci Technol (2011) 2:331–51. doi:10.1146/annurev-food-022510- 
133743 
15. Wang B, Miller JB, McNeil Y, McVeagh P. Sialic acid concentration of brain 
gangliosides: variation among eight mammalian species. Comp Biochem 
Physiol (1998) 119(1):435–9. doi:10.1016/S1095-6433(97)00445-5 
16. Wang B, Hu H, Yu B. Molecular characterization of pig ST8Sia IV – a critical 
gene for the formation of neural cell adhesion molecule and its response 
to sialic acid supplement in piglets. Nutr Neurosci (2006) 9(3–4):147–54. 
doi:10.1080/10284150600903594 
17. Jacobi SK, Yatsunenko T, Li D, Dasgupta S, Yu RK, Berg BM, et al. Dietary 
isomers of sialyllactose increase ganglioside sialic acid concentrations in 
the corpus callosum and cerebellum and modulate the colonic microbiota 
of formula-fed piglets. J Nutr (2016) 146(2):200–8. doi:10.3945/jn.115. 
220152 
18. Aldredge DL, Geronimo MR, Hua S, Nwosu CC, Lebrilla CB, Barile D. 
Annotation and structural elucidation of bovine milk oligosaccharides 
and determination of novel fucosylated structures. Glycobiology (2013) 
23(6):664–76. doi:10.1093/glycob/cwt007 
19. De Leoz MLA, Wu S, Strum JS, Niñonuevo MR, Gaerlan SC, Mirmiran M, 
et al. A quantitative and comprehensive method to analyze human milk oli-
gosaccharide structures in the urine and feces of infants. Anal Bioanal Chem 
(2013) 405:4089–105. doi:10.1007/s00216-013-6817-1 
20. Ninonuevo M, Perkins P, Francis J, Lamotte L, LoCascio R, Freeman S, et al. 
Daily variations in oligosaccharides of human milk determined by micro-
fluidic chips and mass spectrometry. J Agric Food Chem (2008) 56:618–26. 
doi:10.1021/jf071972u 
21. Wu S, Grimm R, German JB, Lebrilla CB. Annotation and structural analysis 
of sialylated human milk oligosaccharides. J Proteome Res (2011) 10:856–68. 
doi:10.1021/pr101006u 
22. Wu S, Tao N, German JB, Grimm R, Lebrilla CB. Development of an anno-
tated library of neutral human milk oligosaccharides. J Proteome Res (2010) 
9:4138–51. doi:10.1021/pr1003 
23. Albrecht S, Lane JA, Marin K, Hickey RM, Al Busadah KA, Carrington SD, 
et al. A comparative study of free oligosaccharides in the milk of domestic 
animals. Br J Nutr (2014) 111:1313–28. doi:10.1017/S0007114513003772 
24. Cheng L, Xu Q, Yang K, He J, Chen D, Du Y, et  al. Annotation of porcine 
milk oligosaccharides throughout lactation by hydrophilic interaction chro-
matography coupled with quadruple time of flight tandem mass spectrometry. 
Electrophoresis (2016) 37(11):1525–31. doi:10.1002/elps.201500471 
25. Tao N, Ochonicky K, German J, Donovan S, Lebrilla C. Structural determina-
tion and daily variations of porcine milk oligosaccharides. J Agric Food Chem 
(2010) 58(8):4653–9. doi:10.1021/jf100398u 
26. National Research Council (US). Nutrient Requirements of Swine (11th rev.). 
Washington, DC: National Research Council (US) (2012).
27. Sundekilde U, Barile D, Meyrand M, Poulsen N, Larsen L, Lebrilla C, et al. 
Natural variability in bovine milk oligosaccharides from danish jersey and 
holstein-friesian breeds. J Agric Food Chem (2012) 60:6188–96. doi:10.1021/
jf300015j 
28. Martin-Ortiz A, Salcedo J, Darile D, Bunyatratchata A, Moreno FJ, Martin-
Garcia I, et  al. Characterization of goat colostrum oligosaccharides by 
nano-liquid chormatography on chim quadrupole time-of-flight mass 
spectrometry and hydrophilic interaction liquid choromatography-quadru-
pole mass spectrometry. J Chromatogr A (2015) 1428:143–53. doi:10.1016/j.
chroma.2015.09.060 
29. Angata T, Varki A. Chemical diversity in the sialic acids and related a-keto 
acids: an evolutionary perspective. Chem Rev (2002) 102:439–69. doi:10.1021/
cr000407m 
30. Bao Y, Chen C, Newburg DS. Quantification of neutral human milk oligosac-
charides by graphitic carbon high-performance liquid chromatography with 
tandem mass spectrometry. Anal Biochem (2013) 433(1):28–35. doi:10.1016/j.
ab.2012.10.003 
31. Hong Q, Ruhaak LR, Totten SM, Smilowitz JT, German JB, Lebrilla CB. 
Label-free absolute quantitation of oligosaccharides using multiple reaction 
monitoring. Anal Chem (2014) 86:2640–7. doi:10.1021/ac404006z 
32. Fong B, Ma K, Mcjarrow P. Quantification of bovine milk oligosaccharides 
using liquid chromatography-selected reaction monitoring-mass spectrome-
try. J Agric Food Chem (2011) 59:9788–95. doi:10.1021/jf202035m 
10
Mudd et al. Oligosaccharide Characterization of Porcine Milk
Frontiers in Nutrition | www.frontiersin.org September 2016 | Volume 3 | Article 39
33. Liu Z, Moate P, Cocks B, Rochfort S. Simple liquid chromatography − mass 
spectrometry method for quantification of major free oligosaccharides in 
bovine milk. J Agric Food Chem (2014) 62:11568–74. doi:10.1021/jf5037849 
34. Nakamura T, Kawase H, Kimura K, Watanabe Y, Ohtani M, Arai I, et  al. 
Concentrations of sialyloligosaccharides in bovine colostrum and milk 
during the prepartum and early lactation. J Dairy Sci (2003) 86(4):1315–20. 
doi:10.3168/jds.S0022-0302(03)73715-1 
35. Kun-tian T, Li-na L, Ya-qi CAI, Shi-fen MOU. Determination of sialic acid in 
milk and products using high performance anion-exchange chromatography 
coupled with pulsed amperometric detection. Chin J Anal Chem (2008) 
36(11):1535–8. doi:10.1016/S1872-2040(09)60005-0 
36. Martin-Sosa S, Martin M, Garcia-Pardo L, Hueso P. Distribution of sialic 
acids in the milk of Spanish mothers of full term infants during lacta-
tion. J Pediatr Gastroenterol Nutr (2004) 39:499–503. doi:10.1097/00005176- 
200411000-00010 
37. Wang B, Brand-Miller J, Mcveagh P, Petocz P. Concentration and distribution 
of sialic acid in human milk and infant formula. Am J Clin Nutr (2001) 
74(4):510–5.
38. Martin M, Martin-Sosa S, Garcia-Prado L, Hueso P. Distribution of bovine 
milk sialoglycoconjugates during lactation. J Dairy Sci (2001) 84(5):995–1000. 
doi:10.3168/jds.S0022-0302(01)74558-4 
Conflict of Interest Statement: BB and MC are employees of Mead Johnson 
Pediatric Nutrition Institute.
The remaining authors declare that the research was conducted in the absence of 
any commercial or financial relationships that could be construed as a potential 
conflict of interest.
Copyright © 2016 Mudd, Salcedo, Alexander, Johnson, Getty, Chichlowski, Berg, 
Barile and Dilger. This is an open-access article distributed under the terms of 
the Creative Commons Attribution License (CC BY). The use, distribution or 
reproduction in other forums is permitted, provided the original author(s) or 
licensor are credited and that the original publication in this journal is cited, in 
accordance with accepted academic practice. No use, distribution or reproduction 
is permitted which does not comply with these terms.
